TrialPloS one2014

Phase I randomized clinical trial of VRC DNA and rAd5 HIV-1 vaccine delivery by intramuscular (i.m.), subcutaneous (s.c.) and intradermal (i.d.) administration (VRC 011).

Mary E Enama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.